Benjamin F. Edwards & Company’s Pfizer PFE Stock Holding History

Benjamin F. Edwards & Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$6.75M	Sell	241,418 -59,241	-20%	-$1.63M	0.12%	184
2024 Q1	$8.34M	Buy	300,659 +130,270	+76%	+$3.61M	0.15%	157
2023 Q4	$4.91M	Buy	170,389 +24,028	+16%	+$726K	0.1%	204
2023 Q3	$4.86M	Sell	146,361 -1,445	-1%	-$51.1K	0.19%	111
2023 Q2	$5.42M	Sell	147,806 -2,330	-2%	-$90.7K	0.21%	104
2023 Q1	$6.13M	Sell	150,136 -4,251	-3%	-$184K	0.26%	86
2022 Q4	$7.91M	Sell	154,387 -5,697	-4%	-$273K	0.36%	70
2022 Q3	$7M	Sell	160,084 -2,806	-2%	-$136K	0.35%	76
2022 Q2	$8.54M	Buy	162,890 +10,473	+7%	+$534K	0.41%	62
2022 Q1	$7.89M	Buy	152,417 +1,814	+1%	+$94.1K	0.35%	73
2021 Q4	$8.89M	Sell	150,603 -292	-0.2%	-$14.5K	0.4%	64
2021 Q3	$6.49M	Buy	150,895 +2,620	+2%	+$116K	0.33%	74
2021 Q2	$5.81M	Buy	148,275 +10,536	+8%	+$410K	0.3%	82
2021 Q1	$4.99M	Buy	137,739 +16,134	+13%	+$573K	0.27%	85
2020 Q4	$4.48M	Sell	121,605 -11,967	-9%	-$439K	0.27%	89
2020 Q3	$4.65M	Sell	133,572 -2,932	-2%	-$103K	0.31%	75
2020 Q2	$4.24M	Buy	136,504 +615	+0.5%	+$20.9K	0.31%	76
2020 Q1	$4.21M	Buy	135,889 +7,720	+6%	+$263K	0.36%	69
2019 Q4	$4.76M	Buy	128,169 +14,374	+13%	+$512K	0.34%	74
2019 Q3	$3.88M	Buy	113,795 +3,361	+3%	+$122K	0.3%	80
2019 Q2	$4.54M	Buy	110,434 +26,800	+32%	+$1.06M	0.38%	57
2019 Q1	$3.37M	Buy	83,634 +721	+0.9%	+$28.9K	0.31%	81
2018 Q4	$3.43M	Sell	82,913 -11,771	-12%	-$489K	0.36%	68
2018 Q3	$3.96M	Buy	94,684 +3,193	+3%	+$123K	0.37%	64
2018 Q2	$3.15M	Sell	91,491 -3,452	-4%	-$118K	0.31%	78
2018 Q1	$3.2M	Sell	94,943 -3,878	-4%	-$133K	0.33%	68
2017 Q4	$3.4M	Sell	98,821 -2,697	-3%	-$92K	0.35%	69
2017 Q3	$3.44M	Buy	101,518 +2,915	+3%	+$93.7K	0.41%	55
2017 Q2	$3.14M	Buy	98,603 +4,932	+5%	+$156K	0.41%	57
2017 Q1	$3.04M	Buy	93,671 +11,607	+14%	+$366K	0.45%	54
2016 Q4	$2.53M	Buy	82,064 +2,223	+3%	+$67.9K	0.41%	60
2016 Q3	$2.57M	Buy	79,841 +20,776	+35%	+$695K	0.45%	53
2016 Q2	$1.97M	Buy	59,065 +676	+1%	+$21.6K	0.38%	61
2016 Q1	$1.64M	Buy	58,389 +679	+1%	+$19.4K	0.34%	66
2015 Q4	$1.77M	Sell	57,710 -469	-0.8%	-$14.8K	0.38%	58
2015 Q3	$1.73M	Sell	58,179 -6,436	-10%	-$206K	0.38%	65
2015 Q2	$2.06M	Buy	64,615 +7,722	+14%	+$252K	0.41%	54
2015 Q1	$1.88M	Buy	56,893 +1,989	+4%	+$63.2K	0.39%	57
2014 Q4	$1.62M	Sell	54,904 -19,266	-26%	-$552K	0.38%	58
2014 Q3	$2.08M	Sell	74,170 -3,261	-4%	-$91.5K	0.52%	45
2014 Q2	$2.18M	Sell	77,431 -1,784	-2%	-$50.9K	0.55%	39
2014 Q1	$2.41M	Sell	79,215 -3,948	-5%	-$118K	0.66%	31
2013 Q4	$2.42M	Sell	83,163 -2,732	-3%	-$79.5K	0.81%	26
2013 Q3	$2.34M	Sell	85,895 -161	-0.2%	-$4.38K	0.87%	25
2013 Q2	$2.29M	Buy	+86,056	New	+$2.38M	0.92%	23

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Benjamin F. Edwards & Company's PFE Position: Q2 2024 in Review

Benjamin F. Edwards & Company reduced its Pfizer (PFE) stake by 20% in Q2 2024, selling an estimated $1.63M and leaving 241,418 shares worth $6.75M. The position accounts for 0.12% of the portfolio, ranked #184.

Benjamin F. Edwards & Company first reported a position in PFE in Q2 2013 and has held it in 45 quarters since. The position peaked at $8.89M in Q4 2021. 2,874 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

Benjamin F. Edwards & Company held 241,418 shares of Pfizer worth $6.75M as of Q2 2024.
Benjamin F. Edwards & Company sold 59,241 Pfizer shares in Q2 2024, an estimated $1.63M.
Pfizer made up 0.12% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #184 holding.
Benjamin F. Edwards & Company first reported a position in Pfizer in Q2 2013 and has held it in 45 quarters since.
Benjamin F. Edwards & Company's Pfizer position peaked at $8.89M in Q4 2021.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.